Invention Grant
US08574581B2 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereof
有权
血液凝集素和流感病毒H5亚型或N1亚型的神经氨酸酶特异性单克隆抗体及其用途
- Patent Title: Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereof
- Patent Title (中): 血液凝集素和流感病毒H5亚型或N1亚型的神经氨酸酶特异性单克隆抗体及其用途
-
Application No.: US13610021Application Date: 2012-09-11
-
Publication No.: US08574581B2Publication Date: 2013-11-05
- Inventor: Hong Liang Qian , Fang He , Hwei-Sing Kwang
- Applicant: Hong Liang Qian , Fang He , Hwei-Sing Kwang
- Applicant Address: SG Singapore
- Assignee: Temasek Life Sciences Laboratory Limited
- Current Assignee: Temasek Life Sciences Laboratory Limited
- Current Assignee Address: SG Singapore
- Agency: Rothwell, Figg, Ernst & Manbeck P.C.
- Main IPC: A61K39/42
- IPC: A61K39/42 ; C07K16/10 ; C07K17/00 ; C12Q1/70
Abstract:
Monoclonal antibodies and related binding proteins that bind specifically to the envelope glycoprotein of H5 subtypes or neuraminidase glycoprotein of N1 subtypes of avian influenza virus (AIV) are provided. The monoclonal antibodies and related binding proteins are useful for the detection of H5 and N1 subtypes of AIV, including H5N1 subtypes and provide means for the diagnosis, surveillance and treatment of dangerous viral infections.
Public/Granted literature
Information query
